Unknown

Dataset Information

0

Discovery and biological evaluation of N5-substituted 6,7-dioxo-6,7-dihydropteridine derivatives as potent Bruton's tyrosine kinase inhibitors.

ABSTRACT: Bruton's tyrosine kinase (BTK) plays a critical role in B cell receptor (BCR)-mediated signaling pathways responsible for the development and function of B cells, which makes it an attractive target for the treatment of many types of B-cell malignancies. Herein, a series of N5-substituted 6,7-dioxo-6,7-dihydropteridine-based, irreversible BTK inhibitors were reported with IC50 values ranging from 1.9 to 236.6 nM in the enzymatic inhibition assay. Compounds 6 and 7 significantly inhibited the proliferation of Ramos cells which overexpress the BTK enzyme, as well as the autophosphorylation of BTK at Tyr223 and the activation of its downstream signaling molecule PLC?2. Overall, this series of compounds could provide a promising starting point for further development of potent BTK inhibitors for B-cell malignancy treatment.

SUBMITTER: Chen H 

PROVIDER: S-EPMC6071741 | biostudies-literature | 2018 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Discovery and biological evaluation of N5-substituted 6,7-dioxo-6,7-dihydropteridine derivatives as potent Bruton's tyrosine kinase inhibitors.

Chen Haiyang H   Song Peiran P   Diao Yanyan Y   Hao Yongjia Y   Dou Dou D   Wang Wanqi W   Fang Xiaoyu X   Wang Yanling Y   Zhao Zhenjiang Z   Ding Jian J   Li Honglin H   Xie Hua H   Xu Yufang Y  

MedChemComm 20180313 4

Bruton's tyrosine kinase (BTK) plays a critical role in B cell receptor (BCR)-mediated signaling pathways responsible for the development and function of B cells, which makes it an attractive target for the treatment of many types of B-cell malignancies. Herein, a series of N5-substituted 6,7-dioxo-6,7-dihydropteridine-based, irreversible BTK inhibitors were reported with IC<sub>50</sub> values ranging from 1.9 to 236.6 nM in the enzymatic inhibition assay. Compounds <b>6</b> and <b>7</b> signif  ...[more]

Similar Datasets

Unknown Contrasting effects of N5-substituted tetrahydrobiopterin derivatives on phenylalanine hydroxylase, dihydropteridine reductase and nitric oxide synthase.
| S-EPMC1221100 | biostudies-other
Unknown Discovery of 5-Phenoxy-2-aminopyridine Derivatives as Potent and Selective Irreversible Inhibitors of Bruton's Tyrosine Kinase.
| S-EPMC7663149 | biostudies-literature
Unknown Molecular Drug Discovery of Single Ginsenoside Compounds as a Potent Bruton's Tyrosine Kinase Inhibitor.
| S-EPMC7247683 | biostudies-literature
Unknown Discovery of Potent and Selective Tricyclic Inhibitors of Bruton's Tyrosine Kinase with Improved Druglike Properties.
| S-EPMC5467183 | biostudies-literature
Unknown Design, synthesis and biological evaluation of novel 2-phenyl pyrimidine derivatives as potent Bruton's tyrosine kinase (BTK) inhibitors.
| S-EPMC6390688 | biostudies-literature
Unknown Discovery of Substituted 1H-Pyrazolo[3,4-b]pyridine Derivatives as Potent and Selective FGFR Kinase Inhibitors.
| S-EPMC4904267 | biostudies-literature
Unknown Design of Potent and Selective Covalent Inhibitors of Bruton's Tyrosine Kinase Targeting an Inactive Conformation.
| S-EPMC6792172 | biostudies-literature
Unknown Discovery of Tricyclic Pyranochromenone as Novel Bruton's Tyrosine Kinase Inhibitors with in Vivo Antirheumatic Activity.
| S-EPMC7663272 | biostudies-literature
Unknown Discovery of 5-substituted tetrahydronaphthalen-2yl-methyl with N-phenyl-N-(piperidin-4-yl)propionamide derivatives as potent opioid receptor ligands.
| S-EPMC4642887 | biostudies-literature
Unknown Targeting Bruton's Tyrosine Kinase in CLL.
| S-EPMC8261291 | biostudies-literature